Your search returned 2 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. MedStar authors:
  • Cruz, Allan-Louie
PMID:
  • 28453705
Year: 2017
Citation:
  • Annals of Oncology. 28(5):1050-1056, 2017 May 01
Institution:
  • MedStar Washington Hospital Center
Department:
  • Hematology/Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barr PM, Brander DM, Cheson BD, Claxton DF, Cruz AL, Daniel C, Fanning M, Foon K, Gashonia L, Goy A, Henick Bachow S, Hill BT, Howlett C, Isaac K, Kennard KH, Kiselev P, Lamanna N, Lenhart J, Mato AR, Nabhan C, Pu JJ, Schuster SJ, Skarbnik AP, Svoboda J, Timlin C, Ujjani CS, Winter AM, Yacur M, Zent CS
DOI:
Add to cart
2.
A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. MedStar authors:
  • Trivedi, Neel
PMID:
  • 29610115
Year: 2018
Citation:
  • Blood Advances. 2(7):762-768, 2018 Apr 10
Institution:
  • MedStar Washington Hospital Center
Department:
  • Hematology and Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Cheson BD, Khan N, Ramzi P, Skarbnik A, Trivedi N, Ujjani C, Wang H
DOI:
Add to cart
Pages

Powered by Koha